An fMRI Study of Opioid-related Changes in Neural Activity
Completed · Not applicable · Has a placebo group
Conditions studied: Social Acceptance
In brief
The purpose of the study is to explore the effect of blocking opioids on affiliation-related neural activity.
Key facts
- Study ID
- NCT02818036
- Run by
- Tristen Inagaki
- People needed
- 82
- Starts
- 2016-08-01
- Expected to finish
- 2018-06-21
- Last updated by the study team
- 2019-07-23
Who can join
Age: 18 and older, up to 35. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- good health
- between the ages of 18 and 35,
- fluent in English
- right-handed (for the fMRI scan)
You may not qualify if…
- Self-reported current or past diagnoses of physical or mental illness.
- Score on the Patient Health Questionnaire (depressive symptoms) above a 13
- Positive urine drug test (for Tetrahydrocannabinol (THC), Opiates, Cocaine, Amphetamine (AMP), and Methamphetamine (mAMP))
- Positive urine pregnancy test
- Use of any prescription medication, except for birth control
- Use of any over-the-counter medications on the day of the fMRI session and 24 hours after the fMRI session
- Self-reported problems with liver functioning, including hepatitis or liver failure
- Difficulty swallowing or taking pills
- BMI greater than 35 or weight greater than 400 lbs
- Claustrophobia
- Nonremovable metal in the body
Where it is running
- University of Pittsburgh — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.